Pharmaron Beijing Co Ltd (300759) — Cash Flow Reinvestment Rate
Pharmaron Beijing Co Ltd (300759) has a Cash Flow Reinvestment Rate of 0.72x as of September 2025, reinvesting CN¥746.35 Million (capex CN¥746.35 Million ) from operating cash flow of CN¥1.04 Billion. Check 300759 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharmaron Beijing Co Ltd Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for Pharmaron Beijing Co Ltd across 11 annual periods. Explore how well can Pharmaron Beijing Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Pharmaron Beijing Co Ltd (2014–2024)
Year-by-year capital reinvestment analysis for Pharmaron Beijing Co Ltd. For live market cap and broader valuation context, see 300759 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.81x | CN¥2.09 Billion | CN¥2.58 Billion | CN¥2.04 Billion | ▼ -56.3% |
| 2023 | 1.86x | CN¥5.12 Billion | CN¥2.75 Billion | CN¥2.87 Billion | ▼ -22.8% |
| 2022 | 2.41x | CN¥5.16 Billion | CN¥2.14 Billion | CN¥2.95 Billion | ▲ +20.5% |
| 2021 | 2.00x | CN¥4.11 Billion | CN¥2.06 Billion | CN¥2.09 Billion | ▲ +27.4% |
| 2020 | 1.57x | CN¥2.59 Billion | CN¥1.65 Billion | CN¥1.32 Billion | ▲ +53.5% |
| 2019 | 1.02x | CN¥959.24 Million | CN¥938.59 Million | CN¥754.61 Million | ▲ +2.2% |
| 2018 | 1.00x | CN¥736.98 Million | CN¥737.26 Million | CN¥640.99 Million | ▼ -46.4% |
| 2017 | 1.87x | CN¥1.03 Billion | CN¥552.22 Million | CN¥934.67 Million | ▼ -79.9% |
| 2016 | 9.31x | CN¥2.19 Billion | CN¥235.77 Million | CN¥1.06 Billion | ▲ +681.7% |
| 2015 | 1.19x | CN¥258.32 Million | CN¥216.94 Million | CN¥258.32 Million | ▼ -82.4% |
| 2014 | 6.75x | CN¥81.94 Million | CN¥12.13 Million | CN¥81.94 Million | — |